The University of Chicago Header Logo

Connection

Thomas Gajewski to Biological Products

Back to Details
This is a "connection" page, showing publications Thomas Gajewski has written about Biological Products.
Thomas Gajewski
Connection Strength
0.038
Biological Products
  1. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. J Clin Oncol. 2023 01 20; 41(3):528-540.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.